Hepatocellular Carcinoma: From Bench to Bedside

4,597
Total downloads
18k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 17 Jul 2025

Differentiation of AFP-negative hepatocellular carcinoma from other intrahepatic malignant lesions by a noninvasive predictive model based on Sonazoid contrast-enhanced ultrasound

Qian Zhang
Zhilong Liu
Ruining Wang
Lele Song
Wenwen Fan
Ping Liang
Liping Liu

doi 10.3389/fonc.2025.1623670

750 views

SYSTEMATIC REVIEW

Published on 18 Jun 2025

Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis

Yani Ke
Yuyan Pan
Xueru Huang
Xing Bai
Xiaojuan Liu
Mingsi Zhang
Tao Jiang
Guangji Zhang

doi 10.3389/fendo.2025.1548924

1,273 views

ORIGINAL RESEARCH

Published on 12 Jun 2025

Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study

Miao Xue
Yanqin Wu
Yiyang Tang
Kun Huang
Haikuan Liu
Bowen Zhu
Jie Wen
Yue Zhao
Guixiong Zhang
2 more
Jiaping Li

doi 10.3389/fimmu.2025.1560750

1,221 views

SYSTEMATIC REVIEW

Published on 09 May 2025

Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis

Dongdong Wu
Ning Liu
Hao Dong
Kan Zhou
Lei Du
Ying Li
Yanjun Chao
Fuping Ma

doi 10.3389/fonc.2025.1504917

1,778 views
1 citation

ORIGINAL RESEARCH

Published on 28 Apr 2025

An immune cell activation signature reflected hepatocellular carcinoma heterogeneity and predicted clinical outcomes

Xiaofeng Wang
Dongli Liu
Shuai Wang
Rui He

doi 10.3389/fimmu.2025.1534611

1,188 views

ORIGINAL RESEARCH

Published on 06 Jan 2025

Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma

Zhengyan Li
Wei Chen
Shu Yao
Zuxiang Peng
Hongming Liu
Yongliang Tang
Yi Feng

doi 10.3389/fimmu.2024.1448878

2,463 views

ORIGINAL RESEARCH

Published on 25 Nov 2024

Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma

Weibin Zhuo
Hongmei Xia
Bin Lan
Yu Chen
Xuefeng Wang
Jingfeng Liu

doi 10.3389/fimmu.2024.1481331

2,260 views
1 citation

ORIGINAL RESEARCH

Published on 01 Nov 2024

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab

Weijie Wu
Zhenyun Yang
Hao Zou
Teng Long
Zhongguo Zhou
Yaojun Zhang
Minshan Chen
Dandan Hu

doi 10.3389/fimmu.2024.1474456

1,441 views
1 citation

ORIGINAL RESEARCH

Published on 08 Oct 2024

Immune cell dynamics and the impact on the efficiency of transvascular antitumor interventional therapies in hepatocellular carcinoma patients

Yuan-Dong Sun
Hao Zhang
Yuan-Min Li
Chun-Xiao Zhou
Jian-Jun Han

doi 10.3389/fimmu.2024.1450525

1,036 views

Share on

Frontiers in Genetics

Cancer Genetics and Oncogenomics

Impact

18kTopic views
12kArticle views
4,597Article downloads

View impact

Articles

Differentiation of AFP-negative hepatocellular carcinoma from other intrahepatic malignant lesions by a noninvasive predictive model based on Sonazoid contrast-enhanced ultrasound

Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis

Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study

Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis

An immune cell activation signature reflected hepatocellular carcinoma heterogeneity and predicted clinical outcomes

Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma

Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab

Immune cell dynamics and the impact on the efficiency of transvascular antitumor interventional therapies in hepatocellular carcinoma patients

Frontiers in Genetics

Cancer Genetics and Oncogenomics